Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950129-04-009637
Filing Date
2004-12-09
Accepted
2004-12-09 16:01:04
Documents
3
Group Members
ESSEX WOODLANDS HEALTH VENTURES FUND V, L.P.ESSEX WOODLANDS HEALTH VENTURES V, L.L.C.IMMANUEL THANGARAJJ. DOUGLAS EPLETTJAMES L. CURRIEMARTIN P. SUTTER

Document Format Files

Seq Description Document Type Size
1 ESSEX WOODLANDS HEALTH VENTURES FUND V, L.P. h20139sc13d.txt SC 13D 39453
2 JOINT FILING AGREEMENT h20139exv99w1.txt EX-99.1 2699
3 COMMON STOCK PURCHASE WARRENT DATED 5/4/2004 h20139exv99w4.txt EX-99.4 21528
  Complete submission text file 0000950129-04-009637.txt   66359
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Subject) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-38110 | Film No.: 041193466
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10001 WOODLOCH FOREST DRIVE STE.175 WOODLANDS TX 77380
Business Address 190 SOUTH LASALLE STREET SUITE 2800 CHICAGO IL 60603
ESSEX WOODLANDS HEALTH VENTURES FUND V LP (Filed by) CIK: 0001120812 (see all company filings)

EIN.: 760647046 | State of Incorp.: DE | Fiscal Year End: 1231